In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels prophetic. In the story, entitled “Peacekeepers of the Immune System,” ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

The Metropolitan Transportation Authority plans to use sensors and cameras to fine overweight trucks that cause $30 million in annual damage to its bridges, beginning with a pilot program on the ...

Weight loss drugs are going oral. Two new medications taken by mouth can help trim body weight in people living with obesity, scientists report in two studies published September 16 and 17 in the New ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Amy Schumer showed off her Mounjaro-fueled transformation via Instagram over the weekend and received gushing comments from her famous friends. The comedian posted a photo of herself and her “lovies” ...

Amy Schumer is showing off her figure. The Trainwreck star debuted a slimmer frame during a recent girls’ trip to Las Vegas with pals Jillian Bell and Alex Saks. In a photo posted on Instagram Oct. 4, ...

The actress and comedian previously opened up about her experiences with weight loss drugs, including Ozempic and Mounjaro Marleen Moise/WireImage; Amy Schumer/Instagram Amy Schumer showed off her ...

Allostatic load refers to the cumulative effects of stress on the body over time. The concept comes from a scientific theory on how stress affects physical health. According to the theory, high or ...

Around 5,000 Americans are diagnosed with amyotrophic lateral sclerosis (ALS) each year. About half of patients die within 14 to 18 months of being diagnosed, usually due to breathing failure. The ...

The GLP-1 agonist at the center of Pfizer’s upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability,” ...